Reportlinker Adds Therapeutics for Memory and Cognition Disord...(p TABLE 50 U.S. PATENTS GRANTED 135...),Health

TABLE 50 U.S. PATENTS GRANTED 135

TABLE 50 (CONTINUED) 136

TABLE 50 (CONTINUED) 137

TABLE 50 (CONTINUED) 138

TABLE 50 (CONTINUED) 139

TABLE 50 (CONTINUED) 140

TABLE 50 (CONTINUED) 141

TABLE 50 (CONTINUED) 142

Chapter-7: OUTLOOK: TRENDS AND CHALLENGES

GENERAL TRENDS 143

GENERAL TRENDS (CONTINUED) 144

ETHICAL IMPLICATIONS 145

ETHICAL IMPLICATIONS (CONTINUED) 146

Chapter-8: COMPANY PROFILES

ACADIA PHARMACEUTICALS 147

ACCERA, INC. 147

ACUMEN PHARMACEUTICALS 147

ALLON THERAPEUTICS (FKA NEURODISCOVERY) 147

ALZHYME PTY 148

AMARIN PHARMACEUTICALS 148

ASTRAZENECA 148

BRAINCELLS, INC. 149

COGNITION PHARMACEUTICALS 149

COLUCID PHARMACEUTICALS 149

COMENTIS 149

CORTEX PHARMACEUTICALS 150

ENVIVO PHARMACEUTICALS 150

GALENEA 150

GLAXOSMITH KLINE 151

HELICON THERAPEUTICS 151

INTELLECT NEUROSCIENCES 151

INTRA-CELLULAR THERAPIES 151

IPSEN 152

LEXICON PHARMACEUTICALS 152

MEDIVATION 152

MEMORY PHARMACEUTICALS 152

MERCK 153

MERCKSERONO 153

MITHRIDION 153

NEUREN PHARMACEUTICALS 153

NEUROSEARCH 153

NEURO-HITECH 154

NEWRON PHARMACEUTICALS 154

NOVARTIS 154

PFIZER 154

PRANA BIOTECHNOLOGY 155

PSYCHOGENICS 155

SANOFI-AVENTIS 155

SATORI PHARMACEUTICALS 155

SCIELE PHARMA 155

SEASIDE THERAPEUTICS 156

SHIRE 156

TAKEDA 156

TARGACEPT 156

TAURX THERAPEUTICS 156

TEVA PHARMACEUTICALS 157

VOYAGER PHARMACEUTICAL / DURAMED 157

WYETH 157

Chapter-9: APPENDIX

COMPANY LISTING 158

ACADIA PHARMACEUTICALS, INC. 158

ACCERA, INC. 158